Search

everythinglearnresearchcommunity

for

Search:↓

Minoxidil mixed with 2-hydroxypropyl-β-cyclodextrin in water can improve hair growth more than minoxidil alone.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

A substance called sodium zinc dihydrolipoylhistidinate can significantly reduce hair loss caused by chemotherapy in rats.

Two different mutations in the vitamin D receptor gene cause different symptoms and responses to treatment in Lebanese patients with hereditary rickets.

Sonidegib effectively treated advanced basal cell carcinoma with mild side effects.

A JAK inhibitor improved both severe hair loss and chronic skin disease in one patient.

High-dose dutasteride reduces PMDD symptoms by stabilizing neurosteroid levels.

PF-998425 is a new, effective, and non-phototoxic treatment for skin conditions related to androgens.

Diphencyprone can cause unexpected and possibly permanent vitiligo.

Combining oral prednisolone and topical minoxidil effectively reduces hair loss and promotes regrowth in alopecia areata.

The new compounds may be more effective and cheaper than current treatments for conditions like baldness.

Low-dose oral minoxidil is an effective and safe treatment for hair loss.

Rubbing vitamin D3 on skin can help prevent hair loss from chemotherapy and slow breast tumor growth in mice.

CS-891 may effectively treat hair loss by blocking enzymes in hair follicles.

Hordenine may help hair grow by activating a specific cell growth pathway.

A certain inhibitor can slow down the decrease in DNA creation in mouse hair follicles, which might help with hair growth.

The new delivery method for dutasteride is more effective and has fewer side effects.

Ritlecitinib effectively reduces hair loss in JAK inhibitor-naïve alopecia areata patients.

Some drugs may cause hair loss in women.

Repurposing existing drugs for COVID-19 shows promise but requires more research to confirm effectiveness.

HVDRR is caused by VDR gene mutations, leading to vitamin D resistance, treatable with high calcium doses, but alopecia remains permanent.

Deoxyshikonin helps wounds heal faster in diabetic mice.

The new gel combining minoxidil and tofacitinib effectively treats alopecia areata by promoting hair growth and reducing inflammation.

The new compound is a promising, less toxic alternative to finasteride for treating prostate issues.

Upadacitinib improved hair regrowth and quality of life in alopecia areata patients with minimal side effects.

Proteasome inhibitors are promising treatments for various cancers, autoimmune diseases, and other conditions.

New compounds were made that are promising for prostate cancer therapy.

Baricitinib helps regrow hair in severe alopecia areata but has side effects like infections and headaches.

Brepocitinib improves cicatricial alopecia and reduces key immune markers.